Nasdaq 100 52-Week Highs & Lows Radar: Vertex Pharmaceuticals, (VRTX), Monster Beverage (MNST) and more
MarketsFN Team
Nasdaq 100 52-Week Highs & Lows Radar: Vertex Pharmaceuticals, (VRTX), Monster Beverage (MNST) and more
Screening all 101 Nasdaq 100 constituents for stocks nearest to their 52-week high and their 52-week low. Data as of September 03, 2026. % Realized = 52-week total return.
Legend: RSI > 70 = overbought · RSI < 30 = oversold · Green % Realized = positive 52W return · Red = negative.
📈 Nearest to 52-Week High
Sectors represented: Healthcare (3), Technology (1), Communication Services (1)
| Ticker | Company | Sector | Price Last | % Realized | 52-Week High Date | RSI | % above MA200 | Trend |
|---|---|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals, Inc | Healthcare | $557.14 | +40.47% | 2026-09-03 | 67.2 | +19.7% | Above MA20, MA50, MA200 |
| TEAM | Atlassian Corporation | Technology | $197.12 | +15.49% | 2026-09-03 | 76.0 | +80.7% | Above MA20, MA50, MA200 |
| EA | Electronic Arts, Inc | Communication Services | $209.70 | +0.38% | 2026-08-04 | — | — | — |
| BIIB | Biogen Inc | Healthcare | $221.93 | +56.70% | 2026-09-02 | 60.7 | +16.3% | Above MA20, MA50, MA200 |
| AMGN | AMGEN Inc | Healthcare | $441.08 | +55.39% | 2026-08-24 | 66.3 | +23.2% | Above MA20, MA50, MA200 |
VRTX | Vertex Pharmaceuticals, Inc | Healthcare | Price Last: $557.14 | % Realized: +40.47% | RSI: 67.2 | % above MA200: +19.7% | Trend: Above MA20, MA50, MA200
Vertex Pharmaceuticals, Inc is a biotechnology company that develops and commercializes transformative medicines for serious diseases, notably cystic fibrosis, with its highly successful product portfolio driving significant revenue growth, making it an attractive investment opportunity for those seeking exposure to the biotech sector.
Vertex Pharmaceuticals exhibits strong technical momentum with an RSI(14) of 67.2, indicating upward price momentum, and a bullish MA alignment (price > MA20 > MA50 > MA200), suggesting a sustained uptrend; it's near its 52-Week high, at 0.0% below, indicating potential for a breakout.
Related headlines
- Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform
- Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
- Vertex to Participate in Upcoming September Investor Conferences
- Vertex Stock Jumps 5.9% as Rival Cystic Fibrosis Drug Fails
TEAM | Atlassian Corporation | Technology | Price Last: $197.12 | % Realized: +15.49% | RSI: 76.0 | % above MA200: +80.7% | Trend: Above MA20, MA50, MA200
Atlassian Corporation is a software company that provides collaboration and productivity tools like Jira and Trello. Investors should care because its products are widely adopted by enterprises, driving growth and profitability.
Atlassian's technicals indicate strong momentum: RSI(14) is 76.0, and the stock is in a sustained uptrend with price > MA20 > MA50 > MA200. It's 0.0% below its 52-Week high, suggesting a potential breakout.
Related headlines
EA | Electronic Arts, Inc | Communication Services | Price Last: $209.70 | % Realized: +0.38% | RSI: — | % above MA200: — | Trend: —
Electronic Arts, Inc (EA) is a leading interactive entertainment software company that develops and publishes games such as FIFA, Madden NFL, and The Sims. Investors care due to its significant market share and recurring revenue from popular franchises.
The stock is near a potential breakout level, 0.0% below its 52-Week high. However, RSI(14) and MA alignment data are unavailable, making it difficult to assess momentum. The stock has returned 0.4% over the 52-Week period.
BIIB | Biogen Inc | Healthcare | Price Last: $221.93 | % Realized: +56.70% | RSI: 60.7 | % above MA200: +16.3% | Trend: Above MA20, MA50, MA200
Biogen Inc is a biotechnology company that develops treatments for neurological and neurodegenerative diseases. Investors should care because its therapies for conditions like multiple sclerosis have significant market potential and the company's pipeline impacts its growth prospects.
Biogen's current technical situation indicates sustained uptrend with price > MA20 > MA50 > MA200, RSI(14) at 60.7, and is 0.3% below its 52-Week high, suggesting momentum with a potential breakout.
Related headlines
- Stoke Therapeutics and Biogen to present four-year zorevunersen data at epilepsy congress
- Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- Biogen Completes Acquisition of RayThera Inc.
AMGN | AMGEN Inc | Healthcare | Price Last: $441.08 | % Realized: +55.39% | RSI: 66.3 | % above MA200: +23.2% | Trend: Above MA20, MA50, MA200
AMGEN Inc is a biotechnology company that develops and markets human therapeutics, focusing on innovative treatments for serious illnesses such as cancer, cardiovascular disease, and bone disease, with a diverse portfolio of blockbuster drugs.
AMGN's technicals indicate sustained uptrend with price > MA20 > MA50 > MA200, RSI(14) at 66.3, and is 0.6% below its 52-Week high, suggesting momentum near a potential breakout level, with a 55.4% 52-Week return.
Related headlines
📉 Nearest to 52-Week Low
Sectors represented: Consumer Defensive (2), Communication Services (1), Healthcare (1), Utilities (1)
| Ticker | Company | Sector | Price Last | % Realized | 52-Week Low Date | RSI | % above MA200 | Trend |
|---|---|---|---|---|---|---|---|---|
| MNST | Monster Beverage Corp | Consumer Defensive | $44.44 | -30.03% | 2026-09-02 | 40.9 | -43.0% | Below MA20, MA50, MA200 |
| EA | Electronic Arts, Inc | Communication Services | $209.70 | +0.38% | 2026-07-17 | — | — | — |
| IDXX | Idexx Laboratories, Inc | Healthcare | $532.35 | -16.03% | 2026-06-30 | 39.1 | -12.4% | Below MA20, MA50, MA200 |
| PEP | PepsiCo Inc | Consumer Defensive | $139.30 | -6.28% | 2026-07-23 | 46.4 | -6.4% | Below MA20, MA50, MA200 |
| EXC | Exelon Corp | Utilities | $44.25 | +2.01% | 2025-09-16 | 42.8 | -3.7% | Below MA20, MA50, MA200 |
MNST | Monster Beverage Corp | Consumer Defensive | Price Last: $44.44 | % Realized: -30.03% | RSI: 40.9 | % above MA200: -43.0% | Trend: Below MA20, MA50, MA200
Monster Beverage Corp is a leading energy drink manufacturer with a portfolio of brands including Monster Energy. Investors care about its performance due to its dominance in the energy drink market and potential for growth or disruption.
The stock is in a sustained downtrend with price ($44.44) below MA20, MA50, and MA200. RSI(14) is 40.9, nearing oversold territory, and is 0.0% above its 52-Week low, indicating a potential support test with a 52-Week return of -30.0%.
Related headlines
EA | Electronic Arts, Inc | Communication Services | Price Last: $209.70 | % Realized: +0.38% | RSI: — | % above MA200: — | Trend: —
Electronic Arts, Inc (EA) is a leading interactive entertainment software company that develops and publishes games such as FIFA, Madden NFL, and The Sims. Investors care due to its significant market share and recurring revenue from popular franchises.
The stock is near a potential breakout level, 0.0% below its 52-Week high. However, RSI(14) and MA alignment data are unavailable, making it difficult to assess momentum. The stock has returned 0.4% over the 52-Week period.
IDXX | Idexx Laboratories, Inc | Healthcare | Price Last: $532.35 | % Realized: -16.03% | RSI: 39.1 | % above MA200: -12.4% | Trend: Below MA20, MA50, MA200
Idexx Laboratories, Inc is a leading provider of veterinary diagnostic and software solutions. Investors should care because its products and services are crucial for the animal healthcare industry, driving revenue growth and profitability.
IDXX's technicals indicate a sustained downtrend with price ($532.35) below MA20, MA50, and MA200. RSI(14) at 39.1 suggests bearish momentum, and being 1.1% above its 52-Week low signals testing of major support, potentially a warning sign.
Related headlines
- IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
- IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
- IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary
- IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ...
PEP | PepsiCo Inc | Consumer Defensive | Price Last: $139.30 | % Realized: -6.28% | RSI: 46.4 | % above MA200: -6.4% | Trend: Below MA20, MA50, MA200
PepsiCo Inc is a diversified food and beverage company with brands like Pepsi, Lay's, and Gatorade, generating revenue through beverage sales, snack foods, and other categories. Investors care about its stable cash flows and dividend yield.
PepsiCo's technicals indicate a warning sign: RSI(14) is 46.4, below MA20/MA50/MA200 with mixed signals, and the stock is only 3.2% above its 52-Week low, testing major support after a -6.3% 52-Week return.
Related headlines
EXC | Exelon Corp | Utilities | Price Last: $44.25 | % Realized: +2.01% | RSI: 42.8 | % above MA200: -3.7% | Trend: Below MA20, MA50, MA200
Exelon Corp is a utility company that generates and distributes electricity, operating nuclear, natural gas, and renewable energy facilities. Investors should care about its stable cash flows and dividend yield, given its role in meeting energy demands.
Exelon Corp's technicals indicate a sustained downtrend with price ($44.25) below MA20, MA50, and MA200. The RSI(14) is 42.8, nearing oversold territory, and the stock is 3.6% above its 52-Week low, testing major support, potentially a warning sign.
Related headlines
- Exelon Announces Key Leadership Position Changes
- Exelon Secures More Than $1 Billion in Customer Protections Through Pioneering Transmission Security Agreements
- Exelon high probability data center load falls 40%
- Exelon Corp (EXC) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles and Data ...
Market Commentary
The Nasdaq 100 stocks listed near 52-week extremes indicate a significant price movement, with some stocks reaching new highs and others hovering near their lows. Stocks like VRTX, TEAM, and EA are at their 52-week highs, while MNST and IDXX are near their 52-week lows, suggesting a divergence in performance within the Nasdaq 100.
The technology sector is driving these price levels, with pharmaceutical and gaming stocks leading the way. Biotech companies like VRTX and BIIB are near 52-week highs, potentially driven by innovation and pipeline progress. In contrast, stocks like MNST and PEP are near their lows, possibly due to concerns over consumer demand and macroeconomic factors.
Key levels to watch include the 52-week extremes for these stocks, as a breakout or breakdown could signal further price movement. For stocks near their highs, such as EA and AMGN, a continued upward trend could be driven by strong earnings or product launches. Conversely, stocks near their lows, like EXC and PEP, may be sensitive to macroeconomic news and sector rotation. Monitoring these levels and potential catalysts will be crucial for investors.
Methodology: All 101 Nasdaq 100 constituents screened. 52-week high = highest daily close over the past 252 trading days (approx. 1 year). 52-week low = lowest daily close over the same period. Distance = (current price / extreme − 1) × 100. Technical indicators computed on up to 1 year of daily OHLCV data.
Disclaimer: For informational purposes only. Not investment advice. Past performance is not indicative of future results.
